Schonfeld Strategic Advisors’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,100
Closed -$255K 2673
2025
Q1
$255K Buy
+25,100
New +$253K ﹤0.01% 1854

Other funds holding TDACU

Schonfeld Strategic Advisors's TDACU Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 25,100 shares — an estimated $255K sold.

Schonfeld Strategic Advisors first reported a position in TDACU in Q1 2025 and held it in 1 quarter. The position peaked at $255K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 25,100 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $255K.
  • Schonfeld Strategic Advisors first reported a position in Translational Development Acquisition Corp Units in Q1 2025 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Translational Development Acquisition Corp Units position peaked at $255K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.